Abel Hall LLC’s Qiagen QGEN Stock Holding History

Abel Hall LLC’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,010	Closed	-$360K	–	944
2025 Q4	$360K	Buy	+8,010	New	+$371K	0.08%	259

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Abel Hall LLC's QGEN Position: Q1 2026 in Review

Abel Hall LLC sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 8,010 shares — an estimated $360K sold.

Abel Hall LLC first reported a position in QGEN in Q4 2025 and held it in 1 quarter. The position peaked at $360K in Q4 2025. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

Abel Hall LLC reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
Abel Hall LLC sold 8,010 Qiagen shares in Q1 2026, an estimated $360K.
Abel Hall LLC first reported a position in Qiagen in Q4 2025 and held it in 1 quarter.
Abel Hall LLC's Qiagen position peaked at $360K in Q4 2025.
344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.